Chidamide, decitabine, cytarabine, aclarubicin, and granulocyte colony-stimulating factor (CDCAG) in patients with relapsed/refractory acute myeloid leukemia: a single-arm, phase 1/2 study

BACKGROUND: Epigenetic mechanisms play an important role in the chemoresistance of acute myeloid leukemia (AML). The clinical response to epigenetic modifier-based chemotherapy in patients with relapsed/refractory AML (r/r AML) is unclear. This multicenter clinical trial evaluated the safety and eff...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Epigenetics
Main Authors: Wang, Lixin, Luo, Jianmin, Chen, Guofeng, Fang, Meiyun, Wei, Xudong, Li, Yinghua, Liu, Zhuogang, Zhang, Yin, Gao, Sujun, Shen, Jianliang, Wang, Xin, Gao, Xiaoning, Zhou, Wei, Ma, Yigai, Liu, Hui, Li, Xinquan, Yang, Linhua, Sun, Kai, Yu, Li
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7466805/
https://ncbi.nlm.nih.gov/pubmed/32873343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-020-00923-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados